BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35093998)

  • 1. Performance of Targeted Congenital Cytomegalovirus Screening in Newborns Failing Universal Hearing Screening: A Multicenter Study.
    Fourgeaud J; Boithias C; Walter-Nicolet E; Kermorvant E; Couderc S; Parat S; Pol C; Mousset C; Bussières L; Guilleminot T; Ville Y; Nkam L; Grimaldi L; Parodi M; Leruez-Ville M
    Pediatr Infect Dis J; 2022 Jun; 41(6):478-481. PubMed ID: 35093998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.
    Williams EJ; Kadambari S; Berrington JE; Luck S; Atkinson C; Walter S; Embleton ND; James P; Griffiths P; Davis A; Sharland M; Clark JE
    Arch Dis Child Fetal Neonatal Ed; 2014 May; 99(3):F230-6. PubMed ID: 24596404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening.
    Ari-Even Roth D; Lubin D; Kuint J; Teperberg-Oikawa M; Mendelson E; Strauss T; Barkai G
    Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F519-F524. PubMed ID: 28468898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program.
    Rawlinson WD; Palasanthiran P; Hall B; Al Yazidi L; Cannon MJ; Cottier C; van Zuylen WJ; Wilkinson M
    J Clin Virol; 2018 May; 102():110-115. PubMed ID: 29571077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: an observational study.
    Yamaguchi A; Oh-Ishi T; Arai T; Sakata H; Adachi N; Asanuma S; Oguma E; Kimoto H; Matsumoto J; Fujita H; Uesato T; Fujita J; Shirato K; Ohno H; Kizaki T
    BMJ Open; 2017 Jan; 7(1):e013810. PubMed ID: 28110288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of congenital CMV infection via DBS samples testing and neonatal hearing screening: an observational study in Italy.
    Pellegrinelli L; Galli C; Primache V; Alde' M; Fagnani E; Di Berardino F; Zanetti D; Pariani E; Ambrosetti U; Binda S
    BMC Infect Dis; 2019 Jul; 19(1):652. PubMed ID: 31331274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing congenital cytomegalovirus detection by pool testing in saliva by a rapid molecular test.
    Izquierdo G; Farfan MJ; Villavicencio L; Montecinos L; Tarque F; Acevedo W; Reyes R; Guerra C; Araya L; Sepúlveda B; Cabrera C; Medina P; Mendez J; Mardones E; Torres JP
    Eur J Pediatr; 2023 Nov; 182(11):5131-5136. PubMed ID: 37684486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooled saliva CMV DNA detection: A viable laboratory technique for universal CMV screening of healthy newborns.
    Shlonsky Y; Smair NS; Mubariki R; Bamberger E; Hemo M; Cohen S; Riskin A; Srugo I; Bader D; Golan-Shany O
    J Clin Virol; 2021 May; 138():104798. PubMed ID: 33770655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn cytomegalovirus screening: is this the new standard?
    Gantt S
    Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):382-387. PubMed ID: 37820202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a Targeted Screening Program for Congenital Cytomegalovirus Infection in Infants Who Fail Newborn Hearing Screening.
    Vancor E; Shapiro ED; Loyal J
    J Pediatric Infect Dis Soc; 2019 Mar; 8(1):55-59. PubMed ID: 29373759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing outcome in congenitally CMV infected children in Finland - Results from follow-up after three years age.
    Puhakka L; Lappalainen M; Lönnqvist T; Nieminen T; Boppana S; Saxen H; Niemensivu R
    Int J Pediatr Otorhinolaryngol; 2022 May; 156():111099. PubMed ID: 35276528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of congenital CMV infection with the presence of CMV DNA in saliva samples of new born babies].
    Zeytinoğlu A; Terek D; Arslan A; Erensoy S; Altun Köroğlu Ö; Bozdemir T; Yalaz M; Ergör SN; Öğüt MF; Kültürsay N
    Mikrobiyol Bul; 2019 Jan; 53(1):53-60. PubMed ID: 30683039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening.
    Fowler KB; McCollister FP; Sabo DL; Shoup AG; Owen KE; Woodruff JL; Cox E; Mohamed LS; Choo DI; Boppana SB;
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28049114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK.
    Kadambari S; Luck S; Davis A; Walter S; Agrup C; Atkinson C; Stimson L; Williams E; Berrington J; Griffiths P; Sharland M
    Eur J Pediatr; 2015 Aug; 174(8):1117-21. PubMed ID: 25743117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay.
    Nagel A; Dimitrakopoulou E; Teig N; Kern P; Lücke T; Michna D; Korn K; Steininger P; Shahada K; Neumann K; Überla K
    PLoS One; 2020; 15(1):e0227143. PubMed ID: 31917817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of congenital cytomegalovirus screening within a newborn hearing screening programme.
    Beswick R; David M; Higashi H; Thomas D; Nourse C; Koh G; Koorts P; Jardine LA; Clark JE
    J Paediatr Child Health; 2019 Nov; 55(11):1381-1388. PubMed ID: 30916438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection.
    Gantt S; Dionne F; Kozak FK; Goshen O; Goldfarb DM; Park AH; Boppana SB; Fowler K
    JAMA Pediatr; 2016 Dec; 170(12):1173-1180. PubMed ID: 27723885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing outcomes in children with Congenital Cytomegalovirus: A multi-center, single-enterprise experience.
    Tapasak B; Cronkite DA; Hustedt-Mai AR; Morlet TM; Parkes WJ; Maul TM; Pritchett CV
    Int J Pediatr Otorhinolaryngol; 2022 Dec; 163():111376. PubMed ID: 36370539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Yield of Targeted Examination for the Detection of Symptomatic Congenital Cytomegalovirus Infection.
    Masarweh K; Felszer-Fisch C; Shinwell E; Hasanein J; Peniakov M; Weiner SA; Lurye-Marcu B; Miron D
    Isr Med Assoc J; 2021 May; 23(5):318-322. PubMed ID: 34024050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cohort study of the universal neonatal urine screening for congenital cytomegalovirus infection.
    Yamada H; Tanimura K; Fukushima S; Fujioka K; Deguchi M; Sasagawa Y; Tairaku S; Funakoshi T; Morioka I
    J Infect Chemother; 2020 Aug; 26(8):790-794. PubMed ID: 32273174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.